Your neurologist will advise the best treatment option for you or your child with SMA. 

Evrysdi is available on the Pharmaceutical Benefits Scheme (PBS) for people of all ages with SMA types 1–3 who have SMA symptoms, or people who do not yet have symptoms but do have one, two or three copies of the SMN2 gene.  

‍